Sui Xin-bing, Zhang Qin, Qiu Hua-sen, Zhou Ji-chun, Gu Xi-dong, Lu Zhou-xiang, Li Chao, Jin Li-jun, Wang Gang
First Clinical Medical College, Zhejiang University of Traditional Chinese Medicine, Hangzhou, Zhejiang Province 310053, China.
Zhong Xi Yi Jie He Xue Bao. 2007 Sep;5(5):521-5. doi: 10.3736/jcim20070509.
To observe the effects of salvianolate on rats with postoperative intestinal adhesion and to explore the prevention mechanism.
Forty SD male rats with intestinal adhesion were randomly divided into four groups: untreated group, low-dose salvianolate-treated group (12 mg/kg), medium-dose salvianolate-treated group (24 mg/kg) and high-dose salvianolate-treated group (48 mg/kg), with another ten SD male rats as normal control. Intraperitoneal injection of glucose was administered to the rats in the normal control group and the untreated group, and intraperitoneal injection of salvianolate was administered to the rats in the low-, medium- and high-dose salvianolate-treated groups. They were all treated for 8 days and once a day. On the eighth day after surgery the blood samples of each group were collected. Grades of intestinal adhesion were ranked by macroscopic observation. The adhesive tissues between viscera and belly wall were taken for pathological observation. The levels of interleukin-1beta (IL-1beta), interleukin-4 (IL-4) and tumor necrosis factor-alpha (TNF-alpha) were determined by enzyme linked immunosorbent assay.
Salvianolate can significantly reduce the extent of postoperative intestinal adhesion, obviously decrease the levels of IL-1beta, TNF-alpha and inhibit the hyperplasy of fibrous connective tissue. However, there was no significant impact on the level of IL-4.
Salvianolate can reduce the extent of postoperative intestinal adhesion, decrease the expression of IL-1beta and TNF-alpha and inhibit the hyperplasy of fibrous connective tissue. This may be the mechanism of salvianolate in preventing intestinal adhesion.
观察丹酚酸对大鼠术后肠粘连的影响并探讨其预防机制。
将40只雄性SD肠粘连大鼠随机分为四组:未治疗组、低剂量丹酚酸治疗组(12mg/kg)、中剂量丹酚酸治疗组(24mg/kg)和高剂量丹酚酸治疗组(48mg/kg),另取10只雄性SD大鼠作为正常对照组。正常对照组和未治疗组大鼠腹腔注射葡萄糖,低、中、高剂量丹酚酸治疗组大鼠腹腔注射丹酚酸。均治疗8天,每日1次。术后第8天采集各组血样。通过肉眼观察对肠粘连程度进行分级。取内脏与腹壁之间的粘连组织进行病理观察。采用酶联免疫吸附测定法测定白细胞介素-1β(IL-1β)、白细胞介素-4(IL-4)和肿瘤坏死因子-α(TNF-α)水平。
丹酚酸可显著降低术后肠粘连程度,明显降低IL-1β、TNF-α水平并抑制纤维结缔组织增生。然而,对IL-4水平无显著影响。
丹酚酸可降低术后肠粘连程度,降低IL-1β和TNF-α表达并抑制纤维结缔组织增生。这可能是丹酚酸预防肠粘连的机制。